Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
59,119,327
-
Total 13F shares
-
35,159,995
-
Share change
-
+3,172,863
-
Total reported value
-
$571,479,438
-
Put/Call ratio
-
16%
-
Price per share
-
$16.25
-
Number of holders
-
109
-
Value change
-
+$57,345,356
-
Number of buys
-
60
-
Number of sells
-
43
Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock (VNDA) as of Q1 2014
As of 31 Mar 2014,
Vanda Pharmaceuticals Inc. - Common Stock (VNDA) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,159,995 shares.
The largest 10 holders included
FMR LLC, BAKER BROS. ADVISORS LP, Palo Alto Investors, LLC, PRICE T ROWE ASSOCIATES INC /MD/, State Street Corp, Invesco Ltd., PAULSON & CO INC, BlackRock Fund Advisors, Consonance Capital Management LP, and KINGDON CAPITAL MANAGEMENT, L.L.C..
This page lists
109
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.